165 related articles for article (PubMed ID: 38254674)
1. The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production.
Chang CM; Liang TR; Lam HYP
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254674
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis.
Guo M; An F; Yu H; Wei X; Hong M; Lu Y
Biomed Pharmacother; 2017 Dec; 96():129-136. PubMed ID: 28972885
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.
Dai X; Yin C; Guo G; Zhang Y; Zhao C; Qian J; Wang O; Zhang X; Liang G
Toxicol Appl Pharmacol; 2018 Nov; 358():110-119. PubMed ID: 30195018
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.
Elgohary S; Eissa RA; El Tayebi HM
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762557
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell.
Yao M; Fan X; Yuan B; Takagi N; Liu S; Han X; Ren J; Liu J
BMC Complement Altern Med; 2019 Aug; 19(1):216. PubMed ID: 31412862
[TBL] [Abstract][Full Text] [Related]
6. Schisandrin B Inhibits NLRP3 Inflammasome Pathway and Attenuates Early Brain Injury in Rats of Subarachnoid Hemorrhage.
Chen S; Ding YH; Shi SS; Tu XK
Chin J Integr Med; 2022 Jul; 28(7):594-602. PubMed ID: 35015222
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin improves lipopolysaccharide-induced acute lung injury by inhibiting the inflammatory response in vivo and in vitro.
Li W; Huang Q; Yu J; Yang Y; Yu J; Liu Y; Song H; Cui L; Niu X
J Food Biochem; 2022 Jul; 46(7):e14141. PubMed ID: 35313003
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 augmented resistance to gemcitabine in triple-negative breast cancer cells via EMT/IL-1β/Wnt/β-catenin signaling pathway.
Zheng Q; Yao D; Cai Y; Zhou T
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32578856
[TBL] [Abstract][Full Text] [Related]
9. Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo.
Leong PK; Ko KM
Biofactors; 2015; 41(5):314-23. PubMed ID: 26307448
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology for systematic understanding of Schisandrin B reduces the epithelial cells injury of colitis through regulating pyroptosis by AMPK/Nrf2/NLRP3 inflammasome.
Zhang W; Wang W; Shen C; Wang X; Pu Z; Yin Q
Aging (Albany NY); 2021 Oct; 13(19):23193-23209. PubMed ID: 34628369
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect and mechanism of deoxyschizandrin on NLRP3 inflammasome].
Cui HR; Li PY; Li YM; Wang RL; He JJ; Sang XX; Cai GM; Niu M; Wang JB; Bai ZF; Xiao XH
Yao Xue Xue Bao; 2017 Jan; 52(1):80-5. PubMed ID: 29911779
[TBL] [Abstract][Full Text] [Related]
12. Schisandrin C: an active compound from the fruit of Schisandra chinensis in anti-inflammation and anti-oxidation.
Kim TW; Hwang S; Park MS; Kim HK; Park MH
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(15):167-173. PubMed ID: 38279455
[TBL] [Abstract][Full Text] [Related]
13. Schisandrin A inhibits triple negative breast cancer cells by regulating Wnt/ER stress signaling pathway.
Xu X; Rajamanicham V; Xu S; Liu Z; Yan T; Liang G; Guo G; Zhou H; Wang Y
Biomed Pharmacother; 2019 Jul; 115():108922. PubMed ID: 31048190
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome activation in peritumoral astrocytes is a key player in breast cancer brain metastasis development.
Mészáros Á; Molnár K; Fazakas C; Nógrádi B; Lüvi A; Dudás T; Tiszlavicz L; Farkas AE; Krizbai IA; Wilhelm I
Acta Neuropathol Commun; 2023 Sep; 11(1):155. PubMed ID: 37749707
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
Yang X; Wang S; Mu Y; Zheng Y
Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
[TBL] [Abstract][Full Text] [Related]
16. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.
Liu Z; Zhang B; Liu K; Ding Z; Hu X
PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q
Yang HL; Lin PY; Vadivalagan C; Lin YA; Lin KY; Hseu YC
Arch Toxicol; 2023 Apr; 97(4):1047-1068. PubMed ID: 36847822
[TBL] [Abstract][Full Text] [Related]
18. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
20. Anti-Inflammatory Effects of Schisandrin B on LPS-Stimulated BV2 Microglia via Activating PPAR-γ.
Liu N; Zheng JX; Zhuang YS; Zhou ZK; Zhao JH; Yang L
Inflammation; 2017 Jun; 40(3):1006-1011. PubMed ID: 28303415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
